Kabra Extrusion Technik Ltd
KABRAEXTRUKabra Extrusion Technik Ltd's price has outrun its earnings. +36.0% in a year against EPS −116.7% — the market is paying now for delivery later.
The sharpest disagreement: the price moved +36.0% in a year while annual EPS moved −116.7% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (3 weeks in) while the P/E sits at the 100th percentile of its own 9-year range. Underneath, the last four quarters read improving, and 69% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Kabra Extrusion Technik Ltd trades at ₹395, in a confirmed uptrend and 3 weeks into that stage. That is +49.1% against its own 200-day average. It sits at 100% of a 52-week range of ₹190 to ₹395. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 7 straight weeks.
Today the stock is in a confirmed uptrend — week 3 of stage 2, confirmed. At ₹395 it trades +49.1% versus its 200-day average and sits at 100% of its 52-week range (₹190–₹395).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +343% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Kabra Extrusion Technik Ltd trades at 1,973.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 29.7×, measured across 8.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 1,973.0× is about the priciest it has ever traded, against a long-run median of 29.7× measured over 8.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −116.7% against a +36.0% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the +13.2%/yr price move, ~−22.4%/yr came from earnings growth and ~+35.6 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Kabra Extrusion Technik Ltd reads as deteriorating on its fundamental arc. Deteriorating — profit and EPS growth are shrinking (profit growth −97.7% latest against +48.1% at its 12-quarter best), ROCE slipping at 0.0%. The read is built from 8 quarters across 4 curves, on partial evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −5.5% | −12.4% | +10.3% | +4.2% |
| Share price | +36.0% | −1.2% | +13.2% | +13.8% |
4-Factor Sector Score
38.8/100 — rank 11 of 16 in Capital Goods - Engineering Heavy · 66% evidence confidence
Kabra Extrusion Technik Ltd scores 38.8 out of 100 against the 16 companies it is compared with in Capital Goods - Engineering Heavy, ranking 11. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 14.7 + 4.7 + 8.7 + 10.7 = 38.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Kabra Extrusion Technik Ltd reported ₹124 Cr of revenue in the Jun 26 quarter, +44.8% year on year. Over 10 years it has compounded at 4.2% a year. The last full year, FY26, came in at ₹451 Cr. The last four reported quarters add to ₹490 Cr.
FY26 revenue came in at ₹451 Cr (−5.5% on the year), capping 10 years at 4.2% compound. The latest quarter (Jun 26) printed ₹124 Cr, +44.8% year on year.
Pace check: the last four quarters averaged +6.8% growth against the decade's 4.2% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +3.1% over the last 4 quarters against −6.7%/yr over the last 8 — accelerating; TTM profit −97.7% vs −87.0%/yr — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Kabra Extrusion Technik Ltd's operating margin is 5.0% in the Jun 26 quarter, +8.4 percentage points against the same quarter a year ago. Across 11 fiscal years the operating margin has ranged 2.3% to 15.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 5.0%, +8.4 pp against the same quarter a year ago. Across 11 fiscal years the operating margin has ranged 2.3%–15.0%.
Why the margin moved: operating margin went +8.4 pp year on year while gross margin went −2.9 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Kabra Extrusion Technik Ltd posted a net loss of ₹1.7 Cr in the Jun 26 quarter. The full FY26 year was a loss of ₹5.0 Cr. That loss is 1.4% of the quarter's revenue. The same quarter a year earlier lost ₹7.6 Cr. 3 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹−1.7 Cr, null year on year. On the full year, FY26 printed ₹−5.0 Cr (−115.6%).
Pace comparison, last four quarters: profit −101.4% vs revenue +6.8%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 69% of Kabra Extrusion Technik Ltd's reported profit arrived as operating cash — most of the profit is real cash. In FY26 that was ₹9.0 Cr of operating cash against ₹−5.0 Cr of profit. After ₹34.0 Cr of capital spending, ₹−25.0 Cr was left as free cash.
FY26: operating cash of ₹9.0 Cr against reported profit of ₹−5.0 Cr, leaving free cash of ₹−25.0 Cr after ₹34.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 69% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 69%: the cash cycle stretched 181 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: conversion is below par and the cash cycle has stretched 181 days — the next section's job is to find where the cash is stuck.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Kabra Extrusion Technik Ltd's cash conversion cycle runs 353 days in FY26, up from 172 days in FY21. Capital spending ran ₹149 Cr over the last 3 years. At FY26 sales of ₹451 Cr each day of that cycle holds about ₹1.2 Cr, so roughly ₹436 Cr sits inside the business at any moment.
FY26: debtors at 65 days, inventory at 373 days — roughly 12.3 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 353 days, looser than FY21's 172.
The full loop: cash goes out to suppliers and production on day 0; stock waits 373 days to sell; customers pay about 65 days after that; and suppliers themselves are paid at 85 days — netting out to the 353-day cycle.
In money terms: at FY26 sales of ₹451 Cr, each day of the cycle holds about ₹1.2 Cr — so the 353-day loop keeps roughly ₹436 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹149 Cr over the last 3 fiscal years against ₹67.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹12.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the working-capital loop is the cash sink the router flagged — watch the cycle, not the P&L.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Kabra Extrusion Technik Ltd earns a ROCE of 0% in FY26. Return on invested capital clears the cost of that capital by −11.3 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −1.1% net margin on 0.59× asset turns.
FY26 ROCE is 0%.
🚨 Why the return is what it is — the wiring (FY26): −1.1% net margin × 0.59× asset turns × 1.74× balance-sheet leverage ≈ −1.1% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 0.7% − 12.0% = a −11.3 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Kabra Extrusion Technik Ltd carries total debt of ₹145 Cr against shareholder equity of ₹441 Cr as of Mar 26, a debt-to-equity of 0.33. On the annual view that ratio went from 0.18 in FY22 to 0.33 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹145 Cr against shareholder equity of ₹441 Cr — a debt-to-equity of 0.33. On the annual view, debt-to-equity went from 0.18 (FY22) to 0.33 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 3.1 points of Kabra Extrusion Technik Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 0.4% of the company. Promoters moved +0.2 points over the same window, to 60.4%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −3.1 points over 8 quarters to 0.4%; Promoters: +0.2 points over 8 quarters to 60.4%; Domestic institutions: +0.0 points over 8 quarters to 0.0%.
🚨 Why the register moved: foreign institutions drove it (−3.1 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Kabra Extrusion Technik Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1JNK India LtdJNKINDIA | 75.3/100Favorable setup79% evidence | LEADER | 30.3/35 Revenue 71.5% · PAT 100% · OPM change 6 pp 88% evidence | 15.6/25 ROCE 17.4% · OPM 14% 100% evidence | 10.2/20 P/E 37.7× · PEG — 15% evidence | 19.2/20 RS sector 24.3% · RS bench 39.1% · 1Y 33.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 30.3 + 15.6 + 10.2 + 19.2 = 75.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Suzlon Energy LtdSUZLON | 67.0/100Favorable setup94% evidence | ASLEEP | 24.4/35 Revenue 45.2% · PAT 50.1% · OPM change -3 pp 100% evidence | 16.9/25 ROCE 35.1% · OPM 16% 100% evidence | 19.3/20 P/E 20.8× · PEG 0.47 100% evidence | 6.4/20 RS sector -7.6% · RS bench -9.8% · 1Y -24.5%7 of 10 weeks ahead 70% evidence |
| Exact sum: 24.4 + 16.9 + 19.3 + 6.4 = 67 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.6% and the one-year return is -24.5%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Disa India LtdDISAQ | 63.5/100Mixed-positive evidence77% evidence | ASLEEP | 18.2/35 Revenue 9.2% · PAT 6% · OPM change 0 pp 83% evidence | 21.3/25 ROCE 26.6% · OPM 17% 95% evidence | 12.7/20 P/E 31.6× · PEG — 50% evidence | 11.3/20 RS sector 3% · RS bench -3.9% · 1Y -14.3%0 of 7 weeks ahead 70% evidence |
| Exact sum: 18.2 + 21.3 + 12.7 + 11.3 = 63.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Concord Control Systems Ltd543619 | 59.3/100Mixed-positive evidence66% evidence | FADING | 21.5/35 Revenue 100% · PAT 100% · OPM change 10 pp 48% evidence | 21.1/25 ROCE 30.6% · OPM 30% 76% evidence | 8.9/20 P/E 62.1× · PEG — 50% evidence | 7.8/20 RS sector -2.5% · RS bench 11.3% · 1Y 131.9%8 of 12 weeks ahead 100% evidence |
| Exact sum: 21.5 + 21.1 + 8.9 + 7.8 = 59.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Bharat Heavy Electricals LtdBHEL | 59.2/100Mixed-positive evidence67% evidence | LEADER | 25.1/35 Revenue 27% · PAT 100% · OPM change 17 pp 71% evidence | 8.3/25 ROCE 9.1% · OPM 7% 76% evidence | 9.6/20 P/E 58.3× · PEG — 15% evidence | 16.2/20 RS sector 19.6% · RS bench 35% · 1Y 69.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25.1 + 8.3 + 9.6 + 16.2 = 59.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6John Cockerill India LtdCOCKERILL | 55.6/100Mixed-positive evidence65% evidence | TURNING | 23.6/35 Revenue 62.6% · PAT 100% · OPM change 2.1 pp 65% evidence | 6.1/25 ROCE 9.4% · OPM 1.4% 100% evidence | 9.1/20 P/E 215.9× · PEG — 15% evidence | 16.8/20 RS sector 28.1% · RS bench 46.6% · 1Y 98.9%8 of 8 weeks ahead 70% evidence |
| Exact sum: 23.6 + 6.1 + 9.1 + 16.8 = 55.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Walchandnagar Industries LtdWALCHANNAG | 49.5/100Mixed-negative evidence65% evidence | FADING | 22.1/35 Revenue 6.2% · PAT 82.9% · OPM change 93.2 pp 62% evidence | 5.0/25 ROCE 4.2% · OPM 4.5% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.4/20 RS sector 3.2% · RS bench 16.4% · 1Y 13%10 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 5 + 10 + 12.4 = 49.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Eimco Elecon (India) LtdEIMCOELECO | 49.1/100Mixed-negative evidence73% evidence | TURNING | 14.1/35 Revenue -14.6% · PAT -4.1% · OPM change 3 pp 71% evidence | 14.4/25 ROCE 13.2% · OPM 20% 95% evidence | 9.5/20 P/E 26.8× · PEG — 50% evidence | 11.1/20 RS sector 0.5% · RS bench 1.2% · 1Y -24.2%3 of 10 weeks ahead 70% evidence |
| Exact sum: 14.1 + 14.4 + 9.5 + 11.1 = 49.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9The Anup Engineering LtdANUP | 46.8/100Mixed-negative evidence83% evidence | TURNING | 13.2/35 Revenue 12.1% · PAT -6.7% · OPM change -4 pp 88% evidence | 21.1/25 ROCE 20.7% · OPM 18% 100% evidence | 4.8/20 P/E 39× · PEG 5.03 65% evidence | 7.7/20 RS sector -11.6% · RS bench 2.1% · 1Y -18.3%7 of 10 weeks ahead 70% evidence |
| Exact sum: 13.2 + 21.1 + 4.8 + 7.7 = 46.8 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 10Integra Engineering India Ltd505358 | 39.8/100Mixed-negative evidence75% evidence | ASLEEP | 9.4/35 Revenue 1.7% · PAT -16.6% · OPM change -3.5 pp 95% evidence | 17.6/25 ROCE 18.5% · OPM 16.4% 76% evidence | 10.0/20 P/E 38.5× · PEG — 15% evidence | 2.8/20 RS sector -27.3% · RS bench -17.2% · 1Y -32.9%9 of 12 weeks ahead 100% evidence |
| Exact sum: 9.4 + 17.6 + 10 + 2.8 = 39.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Kabra Extrusion Technik Ltdthis pageKABRAEXTRU | 38.8/100Mixed-negative evidence66% evidence | TURNING | 14.7/35 Revenue 3.1% · PAT -80% · OPM change 8.4 pp 71% evidence | 4.7/25 ROCE 0.1% · OPM 5% 95% evidence | 8.7/20 P/E 1973× · PEG — 15% evidence | 10.7/20 RS sector -6.2% · RS bench 57.8% · 1Y 35.8%4 of 10 weeks ahead 70% evidence |
| Exact sum: 14.7 + 4.7 + 8.7 + 10.7 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Inox Wind LtdINOXWIND | 38.3/100Mixed-negative evidence83% evidence | ASLEEP | 14.5/35 Revenue 23.5% · PAT 5.9% · OPM change -4 pp 88% evidence | 7.8/25 ROCE 10.5% · OPM 16% 100% evidence | 12.8/20 P/E 33.3× · PEG 1.22 65% evidence | 3.2/20 RS sector -28.6% · RS bench -31.6% · 1Y -50%0 of 10 weeks ahead 70% evidence |
| Exact sum: 14.5 + 7.8 + 12.8 + 3.2 = 38.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Hercules Investments LtdHERCULES | 38.1/100Thin evidence · provisional55% evidence | 13.8/35 Revenue -80% · PAT -74.3% · OPM change 3.7 pp 45% evidence | 7.8/25 ROCE 5.7% · OPM — 60% evidence | 12.7/20 P/E 8.6× · PEG — 50% evidence | 3.8/20 RS sector -23.6% · RS bench -33% · 1Y -46.5%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 13.8 + 7.8 + 12.7 + 3.8 = 38.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Windsor Machines LtdWINDMACHIN | 37.0/100Mixed-negative evidence65% evidence | ASLEEP | 17.9/35 Revenue 54.7% · PAT 45.8% · OPM change -3.2 pp 65% evidence | 3.5/25 ROCE 2.1% · OPM 5.9% 100% evidence | 8.5/20 P/E 2421× · PEG — 15% evidence | 7.1/20 RS sector -10.1% · RS bench -1.2% · 1Y -17.6%7 of 10 weeks ahead 70% evidence |
| Exact sum: 17.9 + 3.5 + 8.5 + 7.1 = 37 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Bajaj Steel Industries LtdBAJAJST | 33.7/100Adverse evidence77% evidence | ASLEEP | 7.0/35 Revenue -10.4% · PAT -56.2% · OPM change -10.9 pp 83% evidence | 13.4/25 ROCE 11.7% · OPM 4.8% 95% evidence | 8.5/20 P/E 22.3× · PEG — 50% evidence | 4.8/20 RS sector -20% · RS bench -15.9% · 1Y -32.2%0 of 7 weeks ahead 70% evidence |
| Exact sum: 7 + 13.4 + 8.5 + 4.8 = 33.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Praj Industries LtdPRAJIND | 22.3/100Adverse evidence90% evidence | ASLEEP | 5.1/35 Revenue -1.9% · PAT -80% · OPM change -6.2 pp 88% evidence | 6.9/25 ROCE 6.1% · OPM 2.8% 100% evidence | 0.5/20 P/E 288× · PEG 4.5 100% evidence | 9.8/20 RS sector 1.4% · RS bench -11% · 1Y -35.5%4 of 10 weeks ahead 70% evidence |
| Exact sum: 5.1 + 6.9 + 0.5 + 9.8 = 22.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Kabra Extrusion Technik Ltd's share price today?
Kabra Extrusion Technik Ltd trades at ₹395, +36.0% over the past year. The company is valued at ₹1,381 Cr. The stock sits at 100% of its 52-week range of ₹190–₹395, +49.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 3 weeks in. — as of 31 July 2026.
What were Kabra Extrusion Technik Ltd's latest quarterly results?
Kabra Extrusion Technik Ltd reported revenue of ₹124 Cr and a net loss of ₹1.7 Cr for the Jun 26 quarter. Earnings per share were ₹−0.50. The operating margin was 5.0%, 8.4 pp higher than a year earlier. — as of 31 July 2026.
What is Kabra Extrusion Technik Ltd's revenue?
Kabra Extrusion Technik Ltd reported revenue of ₹124 Cr in the Jun 26 quarter, +44.8% year on year. For the full FY26 fiscal year, revenue was ₹451 Cr (−5.5%). Over the last 10 years revenue compounded at 4.2% a year. — as of 31 July 2026.
What is Kabra Extrusion Technik Ltd's profit?
Kabra Extrusion Technik Ltd earned ₹−1.7 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹−5.0 Cr. The operating margin ran 5.0% in the latest quarter. — as of 31 July 2026.
What is Kabra Extrusion Technik Ltd's market cap?
Kabra Extrusion Technik Ltd's market capitalisation is ₹1,381 Cr at a share price of ₹395. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Kabra Extrusion Technik Ltd's P/E ratio?
Kabra Extrusion Technik Ltd trades at a P/E of 1,973.0×, at the 100th percentile of its own 9-year range, against a long-run median of 29.7×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Kabra Extrusion Technik Ltd pay a dividend?
Not in its latest year — Kabra Extrusion Technik Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 9 of its last 11 reported fiscal years, so there is a history but no current dividend. — as of 31 July 2026.
Is Kabra Extrusion Technik Ltd overvalued?
On its own history, Kabra Extrusion Technik Ltd looks expensive against its own history: its P/E of 1,973.0× sits at the 100th percentile of its 9-year range (long-run median 29.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
How is Kabra Extrusion Technik Ltd performing?
Kabra Extrusion Technik Ltd is in a confirmed uptrend, 3 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Kabra Extrusion Technik Ltd in?
Deteriorating — profit and EPS growth are shrinking (profit growth −97.7% latest against +48.1% at its 12-quarter best), ROCE slipping at 0.0%. The read comes from the last 12 quarters of growth (revenue growth +3.1% latest, profit growth −97.7% latest, eps growth −97.8% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Kabra Extrusion Technik Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 3 of stage 2), trading +49.1% versus its 200-day average and at 100% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Kabra Extrusion Technik Ltd beating the market?
On recent form, yes — Kabra Extrusion Technik Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 7 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +343% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Kabra Extrusion Technik Ltd's share price go up?
This page publishes no price forecast for Kabra Extrusion Technik Ltd. What it measures instead: the share price is ₹395, the price is in a confirmed uptrend 3 weeks in. Its P/E of 1,973.0× sits at the 100th percentile of its own 9-year range. — as of 31 July 2026.
Who owns Kabra Extrusion Technik Ltd?
Promoters hold 60.4% of Kabra Extrusion Technik Ltd, foreign institutions 0.4%, domestic institutions 0.0% and the public 39.2% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 3.1 points over 8 quarters. — as of 31 July 2026.
Does Kabra Extrusion Technik Ltd have too much debt?
It is moderate — Kabra Extrusion Technik Ltd's debt-to-equity is 0.33, and operating profit covers the interest bill 1×. FY26 borrowings were ₹145 Cr against equity of ₹441 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Kabra Extrusion Technik Ltd's capex?
Kabra Extrusion Technik Ltd spent ₹149 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹34.0 Cr, with ₹12.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Kabra Extrusion Technik Ltd's cash flow?
Kabra Extrusion Technik Ltd generated ₹9.0 Cr of operating cash flow in FY26 and ₹−25.0 Cr of free cash flow after ₹34.0 Cr of capital spending. Reported profit that year was ₹−5.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Kabra Extrusion Technik Ltd's profit real cash?
Mostly — over the last 3 fiscal years, 69% of Kabra Extrusion Technik Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹9.0 Cr against reported profit of ₹−5.0 Cr. The cash then goes mostly into the working-capital cycle. Cash-flow resolution is annual — as of 31 July 2026.
Where is Kabra Extrusion Technik Ltd in its business cycle?
Kabra Extrusion Technik Ltd's FY26 operating margin was 2.3%, against a 11-year band of 2.3%–15.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 5.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Kabra Extrusion Technik Ltd story?
The sharpest disagreement: the price moved +36.0% in a year while annual EPS moved −116.7% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Kabra Extrusion Technik Ltd a stock worth studying right now?
This is not investment advice. The machine read: Kabra Extrusion Technik Ltd's price has outrun its earnings. +36.0% in a year against EPS −116.7% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.